| Product Code: ETC7637202 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Personalized Cancer Vaccines Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Personalized Cancer Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Personalized Cancer Vaccines Market - Industry Life Cycle |
3.4 Ireland Personalized Cancer Vaccines Market - Porter's Five Forces |
3.5 Ireland Personalized Cancer Vaccines Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Ireland Personalized Cancer Vaccines Market Revenues & Volume Share, By Mechanism of Action Type, 2021 & 2031F |
3.7 Ireland Personalized Cancer Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Ireland Personalized Cancer Vaccines Market Revenues & Volume Share, By Bio-Maker Type, 2021 & 2031F |
3.9 Ireland Personalized Cancer Vaccines Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.10 Ireland Personalized Cancer Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Ireland Personalized Cancer Vaccines Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Ireland Personalized Cancer Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Ireland |
4.2.2 Growing awareness about personalized medicine and targeted therapies |
4.2.3 Advancements in technology and genomics for personalized cancer vaccine development |
4.3 Market Restraints |
4.3.1 High cost associated with personalized cancer vaccines |
4.3.2 Regulatory challenges and approval processes for personalized treatments |
4.3.3 Limited infrastructure and expertise for personalized vaccine production in Ireland |
5 Ireland Personalized Cancer Vaccines Market Trends |
6 Ireland Personalized Cancer Vaccines Market, By Types |
6.1 Ireland Personalized Cancer Vaccines Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.1.4 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.5 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.6 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Leukaemia, 2021- 2031F |
6.1.7 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.8 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.2 Ireland Personalized Cancer Vaccines Market, By Mechanism of Action Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Tumour-associated Antigens (TAAs), 2021- 2031F |
6.2.3 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Tumour-specific Antigens (TSAs), 2021- 2031F |
6.2.4 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Somatic Mutations in Cancer Pharmacogenomics, 2021- 2031F |
6.2.5 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Pharmacogenomics towards Genomic Polymorphism, 2021- 2031F |
6.3 Ireland Personalized Cancer Vaccines Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Dendritic Cells (DC) Cancer Vaccines, 2021- 2031F |
6.3.3 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Recombinant Cancer Vaccines, 2021- 2031F |
6.3.4 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Antigen/Adjuvant Cancer Vaccines, 2021- 2031F |
6.3.5 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Viral Vector and DNA Cancer Vaccines, 2021- 2031F |
6.4 Ireland Personalized Cancer Vaccines Market, By Bio-Maker Type |
6.4.1 Overview and Analysis |
6.4.2 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Pharmacogenomics, 2021- 2031F |
6.4.3 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Prognostic and Predictive Biomarkers, 2021- 2031F |
6.4.4 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Immune Checkpoint Biomarkers, 2021- 2031F |
6.4.5 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Ireland Personalized Cancer Vaccines Market, By Treatment Type |
6.5.1 Overview and Analysis |
6.5.2 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Preventive Cancer Vaccines, 2021- 2031F |
6.5.3 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Therapeutic Cancer Vaccines, 2021- 2031F |
6.6 Ireland Personalized Cancer Vaccines Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Injectables, 2021- 2031F |
6.6.3 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Ireland Personalized Cancer Vaccines Market, By End Users |
6.7.1 Overview and Analysis |
6.7.2 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.7.4 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Ireland Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Personalized Cancer Vaccines Market Import-Export Trade Statistics |
7.1 Ireland Personalized Cancer Vaccines Market Export to Major Countries |
7.2 Ireland Personalized Cancer Vaccines Market Imports from Major Countries |
8 Ireland Personalized Cancer Vaccines Market Key Performance Indicators |
8.1 Number of clinical trials utilizing personalized cancer vaccines in Ireland |
8.2 Investment in research and development for personalized cancer vaccines |
8.3 Number of collaborations between pharmaceutical companies and research institutions for personalized cancer vaccine development |
9 Ireland Personalized Cancer Vaccines Market - Opportunity Assessment |
9.1 Ireland Personalized Cancer Vaccines Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Ireland Personalized Cancer Vaccines Market Opportunity Assessment, By Mechanism of Action Type, 2021 & 2031F |
9.3 Ireland Personalized Cancer Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Ireland Personalized Cancer Vaccines Market Opportunity Assessment, By Bio-Maker Type, 2021 & 2031F |
9.5 Ireland Personalized Cancer Vaccines Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.6 Ireland Personalized Cancer Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Ireland Personalized Cancer Vaccines Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Ireland Personalized Cancer Vaccines Market - Competitive Landscape |
10.1 Ireland Personalized Cancer Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Ireland Personalized Cancer Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here